Acadia Healthcare Company, Inc. $ACHC Holdings Lowered by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. reduced its stake in Acadia Healthcare by 0.9%, selling 78,676 shares, and now owns approximately 9.55% of the company, valued at $266.87 million.
• Acadia Healthcare posted earnings of $0.83 per share, surpassing estimates, with a revenue of $869.23 million during the quarter, representing a 9.2% increase year-over-year.
• Analysts have revised their price targets for Acadia Healthcare between $29.00 and $55.00, with a consensus rating of "Moderate Buy" and an average price target of $40.77.

Vanguard Group Inc. lowered its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 0.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,801,781 shares of the company's stock after selling 78,676 shares during the quarter. Vanguard Group Inc. owned approximately 9.55% of Acadia Healthcare worth $266,870,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. boosted its holdings in shares of Acadia Healthcare by 21.4% during the fourth quarter. Russell Investments Group Ltd. now owns 18,421 shares of the company's stock valued at $730,000 after acquiring an additional 3,248 shares during the period. Raymond James Financial Inc. acquired a new position in Acadia Healthcare during the 4th quarter valued at about $5,134,000. Sterling Capital Management LLC grew its position in Acadia Healthcare by 59.1% in the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock worth $216,000 after purchasing an additional 2,026 shares during the last quarter. Barclays PLC increased its stake in shares of Acadia Healthcare by 32.9% in the fourth quarter. Barclays PLC now owns 146,208 shares of the company's stock valued at $5,796,000 after purchasing an additional 36,189 shares during the period. Finally, Mariner LLC raised its holdings in shares of Acadia Healthcare by 88.7% during the fourth quarter. Mariner LLC now owns 16,638 shares of the company's stock valued at $660,000 after buying an additional 7,823 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on ACHC shares. Barclays decreased their price objective on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th. UBS Group decreased their price target on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Raymond James Financial reissued an "outperform" rating and set a $26.00 price target (down from $40.00) on shares of Acadia Healthcare in a report on Thursday, August 14th. KeyCorp reduced their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Finally, Mizuho lowered their target price on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 13th. Nine analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Acadia Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $40.77.

Acadia Healthcare Price Performance

Acadia Healthcare stock traded up $1.02 during midday trading on Friday, hitting $22.44. The company's stock had a trading volume of 1,602,123 shares, compared to its average volume of 2,578,314. Acadia Healthcare Company, Inc. has a 12 month low of $17.13 and a 12 month high of $82.40. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $2.07 billion, a PE ratio of 14.86, a price-to-earnings-growth ratio of 4.42 and a beta of 0.88. The stock's 50-day moving average price is $21.92 and its 200-day moving average price is $26.12.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $869.23 million for the quarter, compared to analysts' expectations of $839.59 million. During the same quarter in the previous year, the company posted $0.91 EPS. The business's revenue was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.